Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab

Overview of attention for article published in Frontiers in immunology, July 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 34,424 followers.

RT @FrontImmunol: New Research: Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab: Primary…

29 Jul 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab: Primary…

27 Jul 2023

Reply Repost Favourite

New Research: Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab: Primary liver cancer is characterized by closely related with chronic liver inflammation, thereby reversing hypoxic… #immunology https://t.co/

27 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.